Maryanna Saenko
Co-founder and Partner @ Future Ventures
San Francisco, United States
Maryanna Saenko is a co-founder of Future Ventures, an early-stage Venture Capital firm that invests in frontier technologies across diverse industries. She has an interest in robotics, quantum computing, biotechnology, aerospace, and the future of food. Previously she was at Khosla Ventures, and prior to that at DFJ, where she focused on frontiertechnology investments. She was also an investment partner at Airbus Ventures where she led a series of venture investments strategically aligned with Airbus’ future-of-aerospace initiatives. Before Airbus, Maryanna was a consultant at Lux Research and a research engineer at Cabot Corporation.Maryanna graduated from Carnegie Mellon University with a BS in BioMedical Engineering and a BS and MS in Materials Science and Engineering.
- Total investments:
- 21
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries Maryanna Saenko invests in
Stages Maryanna Saenko invests in
Countries Maryanna Saenko invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 4 (19%)
- Biotechnology 4 (19%)
- Machine Learning 3 (14%)
- Artificial Intelligence 3 (14%)
- Energy 2 (10%)
Stage
- Series A 6 (29%)
- Seed 4 (19%)
- Series B 4 (19%)
- Pre-Seed 1 (5%)
- Series C 1 (5%)
Country
- United States 11 (52%)
- Germany 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Molten Salt Solutions develops a technology platform to commercialize molten salt synthesis and purification technology. The company was founded in 2018 and is headquartered in Santa Fe, New Mexico. | $7M / Seed / Aug 31, 2026 | ||
| Red Metals is a next-generation copper manufacturing startup building America's first domestic high-conductivity copper rod production facility in Charleston, South Carolina. | $10M / Seed / Jun 04, 2026 | ||
| Pumpkinseed allows for high-speed readings of biological bits. | $20M / Series A / May 05, 2026 | ||
| Commonwealth Fusion Systems develops fusion energy systems using high-temperature superconducting (HTS) magnets to create compact tokamak reactors. It is building SPARC, a demonstration device designed to achieve net energy gain from fusion and laying the groundwork for ARC, a grid-connected fusion power plant targeting early 2030s operation. Thecompany partners with MIT and manufactures its HTS magnets and related components, applying peer-reviewed science in its firewalling of plasma and reactor engineering. It has introduced innovations like the PIT VIPER superconducting cable to support pulsed-power magnet systems and accelerate readiness for commercial fusion. | $863M / Series B / Aug 27, 2025 | ||
| Gameto is a biotechnology company whose mission is to redefine female reproductive health by developing therapies that improve lives.Women’s health is a vastly underserved therapeutic area. Most conditions have few treatment options, and those available often cause frequent complications and offer limited clinical benefit. Gameto aims to changethat.Gameto is committed to using cutting-edge scientific advances to deliver better solutions to patients. Using cellular engineering, they have developed a platform to produce female reproductive cell lines. They use proprietary combinations of transcription factors to reprogram hiPSCs into engineered ovarian and endometrium cell lines that mimic the functions of endogenous cells, producing and responding to all hormones. Their team of cellular engineers is using this platform to advance a portfolio of cellular therapeutics for female reproductive diseases. Gameto's first program, Fertilo, is a therapeutic for IVF and egg freezing, aiming to make the process shorter, safer and more effective. Additional applications of our platform include, an organoid of the female reproductive system, Deovo, and a cell-based therapeutic to ameliorate the health consequences of primary ovarian insufficiency and menopause, Ameno. | $44M / Series C / Aug 12, 2025 | ||
| Realta Fusion develops fusion energy technology for the production of industrial heat and power. It applies advances in super-conducting materials, plasma physics, and computing power to a simple linear fusion reactor configuration. It utilizes abundant fuel sources to provide a zero-carbon source of heat and power. | $36M / Series A / May 13, 2025 | ||
| Molten Salt Solutions develops a technology platform to commercialize molten salt synthesis and purification technology. The company was founded in 2018 and is headquartered in Santa Fe, New Mexico. | $3M / Seed / Oct 24, 2024 | ||
| Gameto is a biotechnology company whose mission is to redefine female reproductive health by developing therapies that improve lives.Women’s health is a vastly underserved therapeutic area. Most conditions have few treatment options, and those available often cause frequent complications and offer limited clinical benefit. Gameto aims to changethat.Gameto is committed to using cutting-edge scientific advances to deliver better solutions to patients. Using cellular engineering, they have developed a platform to produce female reproductive cell lines. They use proprietary combinations of transcription factors to reprogram hiPSCs into engineered ovarian and endometrium cell lines that mimic the functions of endogenous cells, producing and responding to all hormones. Their team of cellular engineers is using this platform to advance a portfolio of cellular therapeutics for female reproductive diseases. Gameto's first program, Fertilo, is a therapeutic for IVF and egg freezing, aiming to make the process shorter, safer and more effective. Additional applications of our platform include, an organoid of the female reproductive system, Deovo, and a cell-based therapeutic to ameliorate the health consequences of primary ovarian insufficiency and menopause, Ameno. | $33M / Series B / May 29, 2024 | ||
| Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry. | $40M / Series B / Oct 03, 2022 | ||
| Gameto is a biotechnology company whose mission is to redefine female reproductive health by developing therapies that improve lives.Women’s health is a vastly underserved therapeutic area. Most conditions have few treatment options, and those available often cause frequent complications and offer limited clinical benefit. Gameto aims to changethat.Gameto is committed to using cutting-edge scientific advances to deliver better solutions to patients. Using cellular engineering, they have developed a platform to produce female reproductive cell lines. They use proprietary combinations of transcription factors to reprogram hiPSCs into engineered ovarian and endometrium cell lines that mimic the functions of endogenous cells, producing and responding to all hormones. Their team of cellular engineers is using this platform to advance a portfolio of cellular therapeutics for female reproductive diseases. Gameto's first program, Fertilo, is a therapeutic for IVF and egg freezing, aiming to make the process shorter, safer and more effective. Additional applications of our platform include, an organoid of the female reproductive system, Deovo, and a cell-based therapeutic to ameliorate the health consequences of primary ovarian insufficiency and menopause, Ameno. | $17M / Venture - Series Unknown / Sep 14, 2022 | ||
| See all 21 investments → | |||
Co-Investors
About Future Ventures
Future Ventures is a financial services platform with a focus on disruptive technology companies such as commercial space exploration, deep learning, quantum computing, robotics, AI, blockchain, sustainable transportation, synthetic biology and clean meat.As venture capitalists, the founders of Future Ventures have led founding investments inseveral companies that had successful IPOs and others that were acquired for over $16 billion in aggregate. Some of our early VC investments include Memphis Meats, Mythic, Nervana, Planet, Rethink Robotics, Skype, SpaceX, Tesla and Zoox. Current board seats include SpaceX, Tesla, and D-Wave.
Future Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Maryanna Saenko
Co-founder and Partner
|
|||
Benjamin A Coppel Sullivan
Limited Partner
|
|||
Steve Jurvetson
Managing Director & Founder
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Maryanna Saenko invest in?
Maryanna Saenko invests primarily in Software, Biotechnology and Machine Learning startups, most often at Series A and Seed stage. Most of the 21 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Maryanna Saenko?
Public channels for Maryanna Saenko include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Maryanna Saenko last invest?
The most recent investment recorded for Maryanna Saenko closed in Aug 2026. Shizune tracks 21 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
